Industry Trends

Latest stories

12 Shares

5 Lessons Learned from the Pandemic for Commercial Life Sciences with Insights from Novartis

2 Shares

A Year of Digital-First Engagement

By The Numbers

Trending Now

1 Shares751 Views0 Comments
in Headlines

Greg Kunst Appointed CEO of Aurion Biotech

Seattle & Boston, June 8 2021 (Business Wire) — Greg Kunst has been named chief executive officer of newly-launched Aurion Biotech, whose mission is to cure blindness by developing a differentiated platform of advanced therapies to treat ocular diseases. The company’s first candidate is a cell therapy for the treatment of corneal endothelial disease, which affects millions of people worldwide, with symptoms that include blurred vision, glare, discomfort and pain. Invented by world-renowned ophthalmic surgeon and research scientist Professor Shigeru Kinoshita and his distinguished colleagues at Kyoto Prefecture University of Medicine (KPUM) in Japan, corneal endothelial cell therapy has demonstrated long-term efficacy in Phase 2 and Phase 3 studies in Japan. More

by hsandm June 9, 2021, 12:31 pm

Read More
752 Views0 Comments
in Headlines

Monogram Health Closes $160M Series B Funding to Fuel Acceleration of Next Generation Kidney Care Model

Nashville, TN., June 8, 2021 (PRNewswire) — Monogram Health, a benefit management and care delivery company transforming care for individuals with chronic kidney and end-stage renal disease, today announced that it has closed a $160 million Series B funding round led by TPG Capital, the private equity platform of global alternative asset firm TPG. The funding round also includes existing investors Frist Cressey Ventures and Norwest Venture Partners, as well as Humana Inc. and other notable national and regional strategic investors. More

by hsandm June 9, 2021, 12:24 pm

Read More
1 Shares775 Views0 Comments
in Headlines

Biogen shares surge 38% after FDA approves Alzheimer’s drug, the first new therapy for the disease in nearly two decades

Cambridge, MA , June 7 2021 (CNBC) — The Food and Drug Administration on Monday approved Biogen’s Alzheimer’s disease drug aducanumab, making it the first medication cleared by U.S. regulators to slow cognitive decline in people living with Alzheimer’s and the first new medicine for the disease in nearly two decades. More

by hsandm June 7, 2021, 12:58 pm

Read More
846 Views0 Comments
in Headlines

venBio Raises $550 Million Venture Capital Fund Focused on Life Sciences

San Francisco, CA June 3 2021 (Business Wire) — venBio today announced the closing of venBio Global Strategic Fund IV, LP (“venBio Fund IV”), its fourth life sciences venture capital fund, exceeding its target and closing on approximately $550 million in capital commitments in an oversubscribed fundraise. The capital was raised from existing and new investors, including a broad range of institutional investors comprising corporate pensions, financial institutions, university endowments and foundations, family offices and funds-of-funds. More

by hsandm June 3, 2021, 1:14 pm

Read More
1 Shares1.4k Views0 Comments
in Headlines

MorphImmune, Inc. Appoints Ronald Martell as President and CEO

San Francisco, June 2, 2021 (PRNewswire) — MorphImmune, Inc., a private platform company that is advancing a highly specific targeting technology that uses a ligand-linked payload to reprogram the immune system, announced the appointment of Ronald Martell as the company’s President and CEO effective April 12, 2021. More

by hsandm June 2, 2021, 12:12 pm

Read More
1 Shares1.5k Views0 Comments
in Headlines

Veracyte to Acquire HalioDx for $318M, Positioning for Global Cancer Diagnostics Growth

South San Francisco, CA , June 1, 2021 (Business Wire) — Veracyte, Inc. (Nasdaq: VCYT) today announced it has reached the terms of an agreement to acquire HalioDx in a transaction to further accelerate growth and strengthen Veracyte’s global leadership in cancer diagnostics. More

by hsandm June 1, 2021, 3:07 pm

Read More

Industry Trends

Latest stories

5 Lessons Learned from the Pandemic for Commercial Life Sciences with Insights from Novartis

A Year of Digital-First Engagement

By The Numbers

More stories

BioPharma’s COVID-19 Response, Market Forecast & M&A

Industry Trends: By the numbers

Beyond COVID-19: Life sciences reimagined

By the numbers

Pharma, Biotech and MedTech Half-Year Review from Evaluate Vantage

Industry Trends: By the numbers

The Orphan Drug Outlook

Metrics on Covid-19: Highlights of the Evaluate Vantage Report

INDUSTRY TRENDS: BY THE NUMBERS

Life Science Industry Outlook: 2019 In Review and 2020 Trends to Watch

INDUSTRY TRENDS: BY THE NUMBERS

VANTAGE 2020 PREVIEW

Greg Kunst Appointed CEO of Aurion Biotech

Monogram Health Closes $160M Series B Funding to Fuel Acceleration of Next Generation Kidney Care Model

Biogen shares surge 38% after FDA approves Alzheimer’s drug, the first new therapy for the disease in nearly two decades

venBio Raises $550 Million Venture Capital Fund Focused on Life Sciences

MorphImmune, Inc. Appoints Ronald Martell as President and CEO

Veracyte to Acquire HalioDx for $318M, Positioning for Global Cancer Diagnostics Growth

Latest stories

More stories

Log In

Sign In

Forgot password?

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

Add to Collection

No Collections